FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series B / Biotech startups that raised Series B in Shanghai, China

Biotech startups that raised Series B in Shanghai, China

Updated 16 Nov 2026

Reset
Biotech startups that raised Series B in Shanghai, China
One-time CSV
  • 53 funded companies, 40 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-b~shanghai-shanghai.csv53 rows × 18 columns
CompanyCityLast roundAmountDate
EnjosimShanghaiSeries B$30.1M2026-11-02
Bluesail SurgicalShanghaiSeries B$104.5M2026-09-23
MindRank AIShanghaiSeries B$52.0M2026-07-08
BivisionShanghaiSeries B$58.8M2026-05-18
NovamabShanghaiSeries B$43.9M2026-04-24
AliothShanghaiSeries B$14.4M2026-01-15
Epigenic TherapeuticsShanghaiSeries B$60.0M2025-09-07
Rona TherapeuticsShanghaiSeries B$25.0M2025-03-14

8 rows of the CSV in 5 of its 18 columns.

53
Startups
$1.9B
Total raised
11
Funded in the last 12 months
$440.7M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

6 of 53
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Enjosim Enjosim researches, manufactures, and sells self-delivery systems for biomacromolecule pharmaceuticals. Biotech Series B $30.1M 2026-11-02 $30.1M Luminous Ventures (former Lightspeed China Partners), Jiayuan Capital 51 to 100 2021
Bluesail Surgical Bluesail Surgical develops surgical instruments for cardiovascular treatments. Biotech Series B $104.5M 2026-09-23 $245.4M Huagai Capital, Linkong Private Equity Fund Management, Linqu County High-Tech Industrial Investment 101 to 250 2020
MindRank AI MindRank AI develops artificial intelligence platforms to discover and develop small molecule drugs. Artificial intelligence Series B $52.0M 2026-07-08 $101.0M Green Pine Capital Partners, Huagai Capital, Sherpa Healthcare Partners +1 11 to 50 2020
Bivision Bivision researches and develops targeted radiopharmaceuticals for therapy. Biotech Series B $58.8M 2026-05-18 $100.9M Gaorong Capital, Kaitai Capital, Lichen Capital 11 to 50 2021
Novamab Novamab researches and develops new nanobodies. Biotech Series B $43.9M 2026-04-24 $97.8M Qiming Venture Partners, Taiyu Investment, Fuho Capital +1 51 to 100 2017
Alioth Alioth develops and applies technical products for pharmaceutical process technology. Biotech Series B $14.4M 2026-01-15 $54.7M Matrix Partners China, Legend Capital 51 to 100 2021

Table 1. Biotech startups that raised Series B in Shanghai, China: the 6 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 53.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 Bluesail Surgical Bluesail Surgical develops surgical instruments for cardiovascular treatments. Biotech Series B $104.5M 2026-09-23 $245.4M Huagai Capital, Linkong Private Equity Fund Management, Linqu County High-Tech Industrial Investment 101 to 250 2020
2 Bivision Bivision researches and develops targeted radiopharmaceuticals for therapy. Biotech Series B $58.8M 2026-05-18 $100.9M Gaorong Capital, Kaitai Capital, Lichen Capital 11 to 50 2021
3 MindRank AI MindRank AI develops artificial intelligence platforms to discover and develop small molecule drugs. Artificial intelligence Series B $52.0M 2026-07-08 $101.0M Green Pine Capital Partners, Huagai Capital, Sherpa Healthcare Partners +1 11 to 50 2020
4 Novamab Novamab researches and develops new nanobodies. Biotech Series B $43.9M 2026-04-24 $97.8M Qiming Venture Partners, Taiyu Investment, Fuho Capital +1 51 to 100 2017
5 Enjosim Enjosim researches, manufactures, and sells self-delivery systems for biomacromolecule pharmaceuticals. Biotech Series B $30.1M 2026-11-02 $30.1M Luminous Ventures (former Lightspeed China Partners), Jiayuan Capital 51 to 100 2021
6 Alioth Alioth develops and applies technical products for pharmaceutical process technology. Biotech Series B $14.4M 2026-01-15 $54.7M Matrix Partners China, Legend Capital 51 to 100 2021

Table 2. Biotech startups that raised Series B in Shanghai, China: the 6 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Huagai Capital Private equity firm Beijing, China 2 4% 2 Bluesail Surgical, MindRank AI
2 Sherpa Healthcare Partners Venture capital firm Beijing, China 2 4% 1 MindRank AI
3 Qiming Venture Partners Venture capital firm Shanghai, China 2 4% 1 Novamab
4 Taiyu Investment Venture capital firm Beijing, China 2 4% 1 Novamab
5 Luminous Ventures (former Lightspeed China Partners) Venture capital firm Shanghai, China 1 2% 1 Enjosim
6 Jiayuan Capital Family office Futian, China 1 2% 1 Enjosim
7 Linqu County High-Tech Industrial Investment 1 2% 1 Bluesail Surgical
8 Linkong Private Equity Fund Management 1 2% 1 Bluesail Surgical
9 Green Pine Capital Partners Venture capital firm Shenzhen, China 1 2% 1 MindRank AI
10 CHERAMI Private equity firm Guangzhou, China 1 2% 1 MindRank AI
11 GL Ventures LLC Venture capital firm Beijing, China 1 2% 1 Etern
12 CICC Investment bank Beijing, China 1 2% 1 Etern
13 Hillhouse Investment Angel group Singapore 1 2% 1 Etern
14 Wuxi Capital Angel group Wuxi Shi, China 1 2% 1 Etern
15 5Y Capital Venture capital firm Xuhui, China 1 2% 1 Etern

Table 3. Biotech startups that raised Series B in Shanghai, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 47 89% $1.9B
Artificial intelligence 3 6% $101.0M
Software 3 6% $101.0M
Hardware 1 2%
Fintech 1 2%
Energy 1 2%

Table 4. Biotech startups that raised Series B in Shanghai, China by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 53 100% $30.0M

Table 5. Biotech startups that raised Series B in Shanghai, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 9% $30.1M
September 2026 2 18% $184.5M
July 2026 1 9% $52.0M
June 2026 1 9%
May 2026 1 9% $58.8M
April 2026 2 18% $58.5M
March 2026 1 9% $14.2M
January 2026 1 9% $14.4M
December 2025 1 9% $28.4M

Table 6. Biotech startups that raised Series B in Shanghai, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 10 19% $412.3M
2025 6 11% $127.3M
2024 2 4%
2023 6 11% $72.0M
2022 8 15% $174.3M
2021 11 21% $690.6M

Table 7. Biotech startups that raised Series B in Shanghai, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 14 26%
2015 to 2019 24 45%
2010 to 2014 12 23%
Before 2010 3 6%

Table 8. Biotech startups that raised Series B in Shanghai, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 2 4%
11 to 50 19 37%
51 to 100 13 25%
101 to 250 9 18%
251 to 500 4 8%
501 to 1,000 2 4%
1,001 to 5,000 2 4%

Table 9. Biotech startups that raised Series B in Shanghai, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Shanghai, China whose last round is Series B are on the list?
53, in the file dated 16 November 2026. 11 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 53 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series B in Shanghai, China: 53 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Shanghai

Other sectors that raised Series B in Shanghai

Cite: FundingWatcher, 53 biotech companies in Shanghai, China whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-b/shanghai-shanghai/